AT1 0.00% 2.8¢ atomo diagnostics limited

Media Update, page-1244

  1. 1,209 Posts.
    lightbulb Created with Sketch. 646
    @Hdavid92
    Sure, understand. yes, the CEO should able to confirm if self-test app was submitted and when.

    Yes, AT1 was waiting on certain aged care trials + a recent trial with Pacific National freight train network to help sway gov opinion (the goal being to demonstrate that Ag RDTs did have a place alongside PCR tests in time critical situations). Both trials would have been done by now (however both were using professional use tests, which already have approval).

    No company has been able to do AU country consumer self-test trials yet (without it being a gov supervised trial) as no company brand has chance of going for TGA self-test approval (till Oct'21).

    Seeing all the brands already approved for self-tests so rapidly since the national policy shift was announced, I doubt any of them have conducted trials here (otherwise AU news would have picked it up). So all the TGA self-test apps (including AT1/Pantonic) are being submitted using consumer trials conducted elsewhere (like Access Bio's USA trials) and these tests already have prior approvals from US/WHO/EU/UK etc

    The Pacific National company trials (using professional tests) + any related gov submission is a Q that could be asked tomorrow. Also more clarity on which orgs/consumer focused groups are actually placing self-test orders. We could also ask if there are large scale consumer trials planned/underway eg: for domestic/international travel usage or shopping centres etc
 
watchlist Created with Sketch. Add AT1 (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.